At the news
? BULLISHIMPACT 7/10 8-K filed Jul 23, 2026 at 06:46 ET
Quest Diagnostics reported Q2 2026 adjusted EPS of $3.12, beating consensus of $2.82 by 10.6%, and revenue of $3.04B, beating $2.97B by 2.5%. The company raised full-year 2026 guidance for the second consecutive quarter, now expecting revenue of $11.95B-$12.05B and adjusted EPS of $11.05-$11.25, driven by 10.2% revenue growth and 19.1% adjusted EPS growth.
- Q2 2026 revenue $3.04B, up 10.2% YoY (10.0% organic)
- Adjusted diluted EPS $3.12, up 19.1% YoY, beat consensus by 10.6%
- Full-year 2026 revenue guidance raised to $11.95B-$12.05B (prior $11.78B-$11.90B)
- Full-year 2026 adjusted EPS guidance raised to $11.05-$11.25 (prior $10.63-$10.83)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access